摘要
Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval]vs placebo 2.30 [1.26- 4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses.
Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval]vs placebo 2.30 [1.26- 4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses.
